Skip to content
— CH. 1 · INTRODUCTION —

Diabetes

13 min listen · Ch. 1 of 8
8 sections
  • In 1500 BCE, an Egyptian manuscript described a strange affliction as "too great emptying of the urine." The complaint would echo across thousands of years and dozens of cultures. The disease is diabetes mellitus, a group of endocrine conditions defined by sustained high blood sugar. Indian physicians once called it madhumeha, or honey urine, because the urine would attract ants. Greek doctors named it after the idea of a siphon, something passing through. Today the numbers are staggering. The count of people diagnosed worldwide rose from 200 million in 1990 to 828 million in 2024. It affects one in seven adults. More than half of those affected do not know they have it. How does a single hormone hold so much sway over the body? Why do its types behave so differently? And how did a condition known to the ancient world become one of the defining health challenges of our age?

  • Insulin is the principal hormone that regulates how glucose moves from the blood into the body's cells, especially in the liver, fat tissue, and muscle. Beta cells in the islets of Langerhans, found in the pancreas, release it in response to rising blood glucose after eating. About two-thirds of the body's cells rely on insulin to absorb glucose for fuel, conversion, or storage. The hormone glucagon works in the opposite manner, prompting the breakdown of stored glycogen back into glucose when levels fall.

    The body draws glucose from three sources. It absorbs glucose from food in the intestine. It breaks down glycogen stored in the liver. And it manufactures glucose from non-carbohydrate substrates through gluconeogenesis. Insulin can inhibit both glycogen breakdown and gluconeogenesis, while pushing glucose into fat and muscle cells for storage.

    When insulin runs short, or cells respond poorly to it, or the insulin itself is defective, this balance collapses. Glucose is not absorbed properly and is not stored in the liver and muscles. The result is persistently high blood glucose, poor protein synthesis, and in complete insulin deficiency, metabolic acidosis. When too much glucose lingers, the kidneys reach a reabsorption threshold and pass the surplus into urine, a condition called glycosuria. That sugary urine pulls water along with it, driving heavy urination and fluid loss. The lost volume is replaced from water inside the body's cells, causing dehydration and intense thirst, while glucose-starved cells stimulate the appetite.

  • The World Health Organization sorts diabetes into six categories: type 1, type 2, hybrid forms, hyperglycemia first detected during pregnancy, other specific types, and unclassified diabetes. Type 1 and type 2 are the major forms, and individuals may even carry a combination of forms.

    Type 1 diabetes accounts for 5 to 10% of cases and is the most common type diagnosed in patients under 20. The older label "juvenile-onset diabetes" has been dropped because onset in adulthood is possible. It is an autoimmune condition in which a T cell-mediated attack destroys the insulin-producing beta cells, leaving severe insulin deficiency. Certain HLA genotypes influence the risk, and twin studies show only about a 50% concordance rate, pointing to inherited risk that is real but not total. When type 1 develops in adults it is called latent autoimmune diabetes of adults, or LADA, with a slower onset than in children. Some use the unofficial term "type 1.5 diabetes," and adults with LADA are frequently misdiagnosed as having type 2 based on age rather than cause.

    Type 2 diabetes is marked by insulin resistance, sometimes combined with reduced insulin secretion, and it accounts for more than 95% of cases. The defective responsiveness is believed to involve the insulin receptor, though the specific defects are not known. It stems primarily from lifestyle factors and genetics. Excess body fat is associated with 30% of cases in people of Chinese and Japanese descent, 60 to 80% in those of European and African descent, and 100% of Pima Indians and Pacific Islanders. Sugar-sweetened drinks raise the risk, saturated and trans fats increase it, and adverse childhood experiences such as abuse and neglect raise the likelihood by 32%, with neglect having the strongest effect.

    Gestational diabetes occurs in about 2 to 10% of all pregnancies and may improve or disappear after delivery. Maturity-onset diabetes of the young, or MODY, is a rare autosomal dominant form making up 1 to 2% of cases, with at least 14 subtypes. Malnutrition-related diabetes, also called type 5, involves decreased insulin production but unlike type 1 does not produce ketonuria or ketosis. Beyond these, researchers have floated unofficial labels: "type 3 diabetes" for the insulin resistance Alzheimer's disease causes in the brain, and "type 4 diabetes" for age-related insulin resistance seen in lean mice.

  • Polydipsia, polyuria, and polyphagia are the three Ps, the classic signs of diabetes meaning excessive thirst, excessive urination, and excessive hunger. They arrive alongside weight loss and blurred vision. Other non-specific signs include fatigue, sweet-smelling urine, and genital itchiness from Candida infection. About half of affected individuals may be asymptomatic. Type 1 presents abruptly after a pre-clinical phase, while type 2 has an insidious onset, and patients may stay symptom-free for years.

    Diabetic ketoacidosis is a medical emergency, most common in type 1, where excessive production of ketone bodies brings nausea, vomiting, abdominal pain, the smell of acetone on the breath, and the deep breathing known as Kussmaul breathing. In severe cases it lowers the level of consciousness. Hyperosmolar hyperglycemic state is another emergency, marked by dehydration from severe hyperglycemia and an altered mental state that can reach coma. Hypoglycemia, a complication of insulin treatment, ranges from sweating, trembling, and palpitations to confusion, seizures, coma, and rarely death.

    Diagnosis rests on measuring blood glucose. A fasting plasma glucose at or above 7.0 mmol/L, which is 126 mg/dL, qualifies, as does a reading at or above 11.1 mmol/L, or 200 mg/dL, two hours after a 75 gram oral glucose load. A glycated hemoglobin, or HbA1C, at or above 48 mmol/mol, which is 6.5 percent, also meets the bar. Between these states lies prediabetes, and as of 2020-38% of all US adults had it.

  • Diabetes doubles the risk of cardiovascular disease, and about 75% of deaths in people with diabetes come from coronary artery disease. The major long-term complications trace back to damage to blood vessels at both the large and small scale. Stroke and peripheral artery disease sit among the larger-vessel harms.

    Diabetic retinopathy, damage to the retina, is the most common cause of blindness in people of working age. The eyes can also develop cataract and glaucoma, which is why people with diabetes are advised to see an optometrist or ophthalmologist once a year. Diabetic nephropathy is a major cause of chronic kidney disease, accounting for over 50% of patients on dialysis in the United States.

    Diabetic neuropathy, nerve damage, shows up as sensory loss, neuropathic pain, and autonomic dysfunction such as postural hypotension and erectile dysfunction. Loss of pain sensation invites injury, leading to diabetic foot problems like ulceration, the most common cause of non-traumatic lower-limb amputation. Hearing loss is another long-term complication. A causal link appears to exist between type 2 diabetes and gallstones, and diabetes increases the risk of dementia, with the risk climbing the earlier one is diagnosed.

  • An HbA1C level below 7% is the goal of treatment, the threshold at which complications grow far less common and less severe. Diabetes management keeps blood sugar close to normal without tipping into low blood sugar, achieved through dietary changes, exercise, weight loss, and appropriate medications. Attention also goes to smoking, high blood pressure, metabolic syndrome, and obesity, all of which can accelerate the disease's harm.

    Type 1 diabetes requires insulin, ideally a basal bolus regimen using long-acting insulin for the basal rate and short-acting insulin with meals. Metformin is the recommended first-line treatment for type 2, working by decreasing the liver's glucose production and increasing glucose stored in peripheral tissue, with good evidence that it lowers mortality. Other drug classes follow: sulfonylureas to increase insulin release, acarbose to slow sugar absorption in the intestines, DPP-4 inhibitors such as sitagliptin, thiazolidinediones to improve insulin sensitivity, and SGLT2 inhibitors to push glucose out in the urine.

    Weight loss surgery in people with obesity and type 2 diabetes is often effective, with many maintaining normal blood sugar afterward and decreased long-term mortality, against a short-term surgical mortality risk of less than 1%. A pancreas transplant is occasionally considered for type 1 patients with severe complications, including end-stage kidney disease. For type 2 diabetes that accounts for 85 to 90% of all cases, prevention is possible: more than 90 minutes of physical activity per day reduces the risk by 28%.

  • In 230 BCE, the Greek Apollonius of Memphis first used the term diabetes, meaning to pass through. The disease was considered rare during the Roman Empire, and the physician Galen said he had seen only two cases in his career, naming it diarrhea of the urine. The earliest surviving detailed account belongs to Aretaeus of Cappadocia, from the 2nd or early 3rd century CE, who attributed the disease to moisture and coldness in keeping with the Pneumatic School of medicine. His work remained unknown in the West until 1552, when the first Latin edition was published in Venice.

    The Indian physicians Sushruta and Charaka, in 400 to 500 CE, were the first to identify two types of diabetes as separate conditions, one tied to youth and another to being overweight. The word mellitus arrived much later. Thomas Willis added it in 1675 after noticing that the urine of a person with diabetes tasted sweet, a sweetness the ancient Greeks, Chinese, Egyptians, and Indians had all observed.

    Effective treatment did not arrive until the early 20th century. The Canadians Frederick Banting and Charles Best isolated and purified insulin in 1921 and 1922, and the long-acting insulin NPH followed in the 1940s. The St. Vincent Declaration of 1989 marked international efforts to improve care for those with the disease.

  • In 2010, diabetes-related emergency room visit rates in the United States reached 526 per 10,000 people in the lowest-income communities, against 236 per 10,000 in the highest-income communities. The disease does not fall evenly. Racial and ethnic minorities carry higher prevalence: US adults overall face a 40% chance of developing type 2 diabetes, while the chance for Hispanic and Latino adults is more than 50%. Among Asian Americans, 1 in 3 cases go undiagnosed, compared with 1 in 5 nationally.

    Diabetes stigma describes the negative judgment and prejudice aimed at people with the disease, often rooted in the idea that type 2 diabetes results from poor lifestyle choices rather than genetics and social determinants of health. Stigma reaches into marriage proposals, employment, and social standing, and it turns inward as self-stigma tied to higher distress and depression. Women fare worse than men: they face more mental health issues such as eating disorders, are three times more likely to be housebound, and seek more medical help while receiving less than men of the same race and economic class.

    The disease is not confined to humans. It is most common in dogs and cats, with female dogs twice as likely to be affected as males, and small breeds such as Miniature Poodles particularly prone. Feline diabetes is strikingly similar to human type 2 diabetes, with the Burmese, Russian Blue, Abyssinian, and Norwegian Forest breeds at higher risk. Birds, by contrast, do not develop diabetes at all, owing to their unusually high tolerance for elevated blood glucose.

Continue Browsing

Common questions

What is diabetes mellitus and what causes it?

Diabetes mellitus is a group of common endocrine diseases characterized by sustained high blood sugar levels. It results either from reduced production of the hormone insulin by the pancreas or from the body's cells being unresponsive to insulin's effects.

What is the difference between type 1 and type 2 diabetes?

Type 1 diabetes is an autoimmune condition in which a T cell-mediated attack destroys the insulin-producing beta cells of the pancreas, and it accounts for 5 to 10% of cases. Type 2 diabetes is marked by insulin resistance, accounts for more than 95% of cases, and stems primarily from lifestyle factors and genetics.

What are the classic symptoms of diabetes?

The classic symptoms of diabetes are the three Ps: polydipsia or excessive thirst, polyuria or excessive urination, and polyphagia or excessive hunger. These appear alongside weight loss and blurred vision, though about half of affected individuals may be asymptomatic.

How many people have diabetes worldwide?

The number of people diagnosed with diabetes worldwide rose from 200 million in 1990 to 828 million in 2024. It affects one in seven adults, and more than half of those affected are unaware of their condition.

How is diabetes diagnosed?

Diabetes is diagnosed by a fasting plasma glucose level at or above 7.0 mmol/L, which is 126 mg/dL, or a plasma glucose at or above 11.1 mmol/L, which is 200 mg/dL, two hours after a 75 gram oral glucose load. A glycated hemoglobin, or HbA1C, at or above 48 mmol/mol, which is 6.5 percent, also confirms the diagnosis.

How is diabetes treated and managed?

Type 1 diabetes requires insulin, ideally a basal bolus regimen of long-acting and short-acting insulin. Type 2 diabetes is generally first treated with metformin and lifestyle changes, with a treatment goal of keeping HbA1C below 7%.

Who discovered insulin for diabetes treatment?

The Canadians Frederick Banting and Charles Best isolated and purified insulin in 1921 and 1922, the first effective treatment for diabetes. The long-acting insulin NPH followed in the 1940s.

All sources

208 references cited across the entry

  1. 1Diabetes Blue Circle SymbolInternational Diabetes Federation — 17 March 2006
  2. 3JournalDiabetic Gastroparesis: Principles and Current Trends in ManagementKrishnasamy S, Abell TL — July 2018
  3. 4JournalDiabetes mellitus and cognitive impairmentsSaedi E, Gheini MR, Faiz F, Arami MA — September 2016
  4. 6Drug Treatment of Diabetes MellitusBrutsaert EF — February 2017
  5. 10Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes AssociationJane L. Chiang — National Library of Medicine — 12 June 2014
  6. 12JournalHyperglycemic crises in adult patients with diabetesKitabchi AE, Umpierrez GE, Miles JM, Fisher JN — July 2009
  7. 13Symptoms and Causes of DiabetesNational Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health — 2024
  8. 19JournalGlobal Economic Burden of Diabetes in Adults: Projections From 2015 to 2030Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, Davies J, Vollmer S — May 2018
  9. 20DiabetesFebruary 17, 2023
  10. 21BookKumar and Clark's Clinical MedicineFeather A, Randall D, Waterhouse M — Elsevier — 2021
  11. 22BookGoldman-Cecil MedicineGoldman L, Schafer A — Elsevier — 2020
  12. 23BookDavidson's Principles and Practice of MedicinePenman I, Ralston S, Strachan M, Hobson R — Elsevier — 2023
  13. 24JournalHyperglycaemic presentations in type 2 diabetesWillix C, Griffiths E, Singleton S — May 2019
  14. 25JournalThe consequences of hypoglycaemiaAmiel SA — May 2021
  15. 28Diabetes – long-term effectsDepartment of Health
  16. 29JournalDiabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesSarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J — June 2010
  17. 30Journal2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesO'Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW — January 2013
  18. 31JournalComplications of Diabetes 2017Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M — 11 March 2018
  19. 32Diabetes eye careNational Library of Medicine
  20. 33BookCecil Essentials of MedicineWing EJ, Schiffman F — Elsevier — 2022
  21. 34JournalA systematic review of the association of Type I diabetes with sensorineural hearing lossMittal R, McKenna K, Keith G, Lemos JR, Mittal J, Hirani K — 9 February 2024
  22. 35JournalObesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization InvestigationYuan S, Gill D, Giovannucci EL, Larsson SC — March 2022
  23. 36JournalCognitive decline and dementia in diabetes--systematic overview of prospective observational studiesCukierman T, Gerstein HC, Williamson JD — December 2005
  24. 38JournalDiabetes mellitus and risk of falls in older adults: a systematic review and meta-analysisYang Y, Hu X, Zhang Q, Zou R — November 2016
  25. 39BookWilliams textbook of endocrinologyElsevier/Saunders — 2011
  26. 41JournalWhat is Type 1 Diabetes?Lambert P, Bingley PJ — 2002
  27. 42JournalCo-aggregation and heritability of organ-specific autoimmunity: a population-based twin studySkov J, Eriksson D, Kuja-Halkola R, Höijer J, Gudbjörnsdottir S, Svensson AM, Magnusson PK, Ludvigsson JF, Kämpe O, Bensing S — May 2020
  28. 43JournalGenetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up studyHyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J — April 2003
  29. 44JournalA study of diabetes mellitus within a large sample of Australian twinsCondon J, Shaw JE, Luciano M, Kyvik KO, Martin NG, Duffy DL — February 2008
  30. 45JournalThe Concordance and Heritability of Type 2 Diabetes in 34,166 Twin Pairs From International Twin Registers: The Discordant Twin (DISCOTWIN) ConsortiumWillemsen G, Ward KJ, Bell CG, Christensen K, Bowden J, Dalgård C, Harris JR, Kaprio J, Lyle R, Magnusson PK, Mather KA, Ordoňana JR, Perez-Riquelme F, Pedersen NL, Pietiläinen KH, Sachdev PS, Boomsma DI, Spector T — December 2015
  31. 46JournalGlobal, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y, Shan PF — September 2020
  32. 47JournalAn Update on the Epidemiology of Type 2 Diabetes: A Global PerspectiveTinajero MG, Malik VS — September 2021
  33. 48ReportClassification of diabetes mellitus 2019World Health Organisation — 2019
  34. 49JournalThe many faces of diabetes: a disease with increasing heterogeneityTuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L — March 2014
  35. 50BookRobbins & Cotran Pathologic Basis of DiseaseKumar V, Abbas A, Aster J — Elsevier — 2021
  36. 51JournalDiabetes treatment--bridging the divideRother KI — April 2007
  37. 52Diabetes Mellitus (DM)Brutsaert EF — Merck Publishing — September 2022
  38. 53JournalMechanisms of Beta Cell Dysfunction Associated With Viral InfectionPetzold A, Solimena M, Knoch KP — October 2015
  39. 54JournalEnvironmental Risk Factors and Type 1 Diabetes: Past, Present, and FutureButalia S, Kaplan GG, Khokhar B, Rabi DM — December 2016
  40. 55JournalGenetic epidemiology of diabetesM. Alan Permutt et al. — 2005-06-01
  41. 56JournalDiabetes: The genetic connectionsD. A. Pyke — 1979-12-01
  42. 57JournalInsulin gene mutations and diabetesMasahiro Nishi et al. — 2011
  43. 59JournalLatent autoimmune diabetes of the adult: current knowledge and uncertaintyLaugesen E, Østergaard JA, Leslie RD — July 2015
  44. 61JournalIdentification and phenotypic characterization of patients with LADA in a population of southeast MexicoNolasco-Rosales GA, Ramírez-González D, Rodríguez-Sánchez E, Ávila-Fernandez Á, Villar-Juarez GE, González-Castro TB, Tovilla-Zárate CA, Guzmán-Priego CG, Genis-Mendoza AD, Ble-Castillo JL, Marín-Medina A, Juárez-Rojop IE — April 2023
  45. 62BookGreenspan's basic & clinical endocrinologyMcGraw-Hill Medical — 2011
  46. 63JournalPathophysiology of Type 2 Diabetes MellitusUnai Galicia-Garcia — 2020-08-30
  47. 64BookStatPearlsFreeman AM, Acevedo LA, Pennings N — StatPearls Publishing — 2024
  48. 65Journal2. Classification and Diagnosis of Diabetes((American Diabetes Association)) — January 2017
  49. 66JournalPrevention of Diabetes Mellitus in Patients With PrediabetesCarris NW, Magness RR, Labovitz AJ — February 2019
  50. 67JournalDietary fats and prevention of type 2 diabetesRisérus U, Willett WC, Hu FB — January 2009
  51. 68JournalRisk factors for type 2 diabetes mellitusFletcher B, Gulanick M, Lamendola C — January 2002
  52. 69JournalA Detailed Review on Diabetes MellitusHrishabh Jha — 2023
  53. 70JournalSugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease riskMalik VS, Popkin BM, Bray GA, Després JP, Hu FB — March 2010
  54. 71JournalSugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysisMalik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB — November 2010
  55. 72JournalSugar-sweetened or artificially sweetened beverage consumption, physical activity and risk of type 2 diabetes in US adultsPacheco LS, Tobias DK, Haslam DE, Drouin-Chartier JP, Li Y, Bhupathiraju SN, Willett WC, Ludwig DS, Ebbeling CB, Hu FB, Guasch-Ferré M — January 2025
  56. 73JournalWhite rice consumption and risk of type 2 diabetes: meta-analysis and systematic reviewHu EA, Pan A, Malik V, Sun Q — March 2012
  57. 74JournalAdverse childhood experiences and risk of type 2 diabetes: A systematic review and meta-analysisHuang H, Yan P, Shan Z, Chen S, Li M, Luo C, Gao H, Hao L, Liu L — November 2015
  58. 75JournalThe metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysisZhang Y, Liu Y, Su Y, You Y, Ma Y, Yang G, Song Y, Liu X, Wang M, Zhang L, Kou C — November 2017
  59. 77JournalKrause's Food & The Nutrition Care ProcessSoldavini J — November 2019
  60. 79JournalIntrapartal cardiotocographic patterns and hypoxia-related perinatal outcomes in pregnancies complicated by gestational diabetes mellitusTarvonen M, Hovi P, Sainio S, Vuorela P, Andersson S, Teramo K — November 2021
  61. 80BookDiabetes in Pregnancy: Management of diabetes and its complications from preconception to the postnatal periodNational Collaborating Centre for Women's and Children's Health — National Institute for Health and Care Excellence (UK) — February 2015
  62. 81JournalProgression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysisVounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL — May 2020
  63. 83BookStatPearlsHoffman LS, Fox TJ, Anastasopoulou C, Jialal I — StatPearls Publishing — 2025
  64. 84JournalDiagnosis and management of maturity onset diabetes of the young (MODY)Thanabalasingham G, Owen KR — October 2011
  65. 86NewsMalnutrition-Related Diabetes Officially Named 'Type 5'Miriam E. Tucker — 11 April 2025
  66. 88JournalInsulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?Cleland SJ, Fisher BM, Colhoun HM, Sattar N, Petrie JR — National Library of Medicine — July 2013
  67. 89BookRobbins Basic PathologyMitchell RS, Kumar V, Abbas AK, Fausto N — Saunders — 2007
  68. 90JournalStatins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsSattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ, Gotto AM, Clearfield MB, Downs JR, Nakamura H, Ohashi Y, Mizuno K, Ray KK, Ford I — February 2010
  69. 93JournalInsulin and insulin resistanceWilcox G — May 2005
  70. 94Insulin BasicsAmerican Diabetes Association
  71. 95BookGanong's review of medical physiologyBarrett KE, etal — McGraw-Hill Medical — 2012
  72. 96BookHarper's illustrated biochemistryMurray RK, etal — McGraw-Hill Medical — 2012
  73. 97BookJuta's Complete Textbook of Medical Surgical NursingMogotlane S — Juta — 2013
  74. 99JournalPostchallenge hyperglycemia and mortality in a national sample of U.S. adultsSaydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL — August 2001
  75. 101JournalDiagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucoseSantaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H — Agency for Healthcare Research and Quality — August 2005
  76. 102JournalThe oral glucose tolerance test (OGTT) revisitedBartoli E, Fra GP, Carnevale Schianca GP — February 2011
  77. 103JournalGlycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adultsSelvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati FL — March 2010
  78. 104JournalUnderstanding Pre-Type 1 Diabetes: The Key to PreventionJacobsen LM, Haller MJ, Schatz DA — 2018-03-06
  79. 105JournalTackling risk factors for type 2 diabetes in adolescents: PRE-STARt study in EuskadiAnales de Pediatría — 2020
  80. 106JournalPhysical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013Kyu HH, Bachman VF, Alexander LT, Mumford JE, Afshin A, Estep K, Veerman JL, Delwiche K, Iannarone ML, Moyer ML, Cercy K, Vos T, Murray CJ, Forouzanfar MH — August 2016
  81. 107Simple Steps to Preventing DiabetesHarvard T.H. Chan School of Public Health — 18 September 2012
  82. 108JournalActive smoking and the risk of type 2 diabetes: a systematic review and meta-analysisWilli C, Bodenmann P, Ghali WA, Faris PD, Cornuz J — December 2007
  83. 109Chronic diseases and their common risk factorsWorld Health Organization — 2005
  84. 110Diabetes and Your Immune SystemCDC — 2023-07-31
  85. 111JournalDiabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerationsSingh AK, Gupta R, Ghosh A, Misra A — 2020
  86. 112JournalDiabetes in COVID-19 pandemic-prevalence, patient characteristics and adverse outcomesAbdelhafiz AH, Emmerton D, Sinclair AJ — July 2021
  87. 113JournalIntensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) GroupSeptember 1998
  88. 114BookWilliams Textbook of EndocrinologyAtkinson MA, Mcgill DE, Dassau E, Laffel L — Elsevier — 2020
  89. 115Managing diabetesNational Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health — 1 December 2016
  90. 116JournalEffectiveness of plant-based diets in promoting well-being in the management of type 2 diabetes: a systematic reviewToumpanakis A, Turnbull T, Alba-Barba I — 2018-10-30
  91. 117JournalThe effect of intensive diabetes therapy on the development and progression of neuropathy.((The Diabetes Control and Complications Trial Research Group)) — April 1995
  92. 118The A1C test and diabetesNational Institute of Diabetes and Digestive and Kidney Diseases, US National Institutes of Health — 1 April 2018
  93. 119JournalHemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of PhysiciansQaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA, Fitterman N, Balzer K, Boyd C, Humphrey LL, Iorio A, Lin J, Maroto M, McLean R, Mustafa R, Tufte J — April 2018
  94. 120JournalFootwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic reviewBus SA, van Deursen RW, Armstrong DG, Lewis JE, Caravaggi CF, Cavanagh PR — January 2016
  95. 121JournalEffectiveness of offloading methods in preventing primary diabetic foot ulcers in adults with diabetes: a systematic reviewHeuch L, Streak Gomersall J — July 2016
  96. 122JournalPrevention of foot ulcers in the at-risk patient with diabetes: a systematic reviewvan Netten JJ, Raspovic A, Lavery LA, Monteiro-Soares M, Rasmussen A, Sacco IC, Bus SA — March 2020
  97. 123JournalPreventive foot care in diabetesMayfield JA, Reiber GE, Sanders LJ, Janisse D, Pogach LM — January 2004
  98. 124JournalSelf management interventions for type 2 diabetes in adult people with severe mental illnessMcBain H, Mulligan K, Haddad M, Flood C, Jones J, Simpson A — April 2016
  99. 125JournalLong-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical TrialsHaw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, Wei J, Narayan KM, Ali MK — December 2017
  100. 126JournalWeight Management in Patients with Type 1 Diabetes and ObesityMottalib A, Kasetty M, Mar JY, Elseaidy T, Ashrafzadeh S, Hamdy O — August 2017
  101. 127Journal5. Lifestyle Management: Standards of Medical Care in Diabetes-2019American Diabetes Association — January 2019
  102. 128JournalNutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus ReportEvert AB, Dennison M, Gardner CD, Garvey WT, Lau KH, MacLeod J, Mitri J, Pereira RF, Rawlings K, Robinson S, Saslow L, Uelmen S, Urbanski PB, Yancy WS — May 2019
  103. 129JournalThe effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groupsEmadian A, Andrews RC, England CY, Wallace V, Thompson JL — November 2015
  104. 130JournalWeight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of ActionGrams J, Garvey WT — June 2015
  105. 131JournalNon-nutritive sweeteners for diabetes mellitusLohner S, Kuellenberg de Gaudry D, Toews I, Ferenci T, Meerpohl JJ — May 2020
  106. 132Pediatric type 2 diabetesTillotson CV, Bowden SA, Shah M, Boktor SW — StatPearls, US National Library of Medicine — 12 November 2023
  107. 133JournalGlobal burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019Xie J, Wang M, Long Z, Ning H, Li J, Cao Y, Liao Y, Liu G, Wang F, Pan A — December 2022
  108. 134JournalISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescentsShah AS, Zeitler PS, Wong J, Pena AS, Wicklow B, Arslanian S, Chang N, Fu J, Dabadghao P, Pinhas-Hamiel O, Urakami T, Craig ME — November 2022
  109. 135JournalDiabetic retinopathy: current concepts and emerging therapyRosberger DF — December 2013
  110. 136JournalGlycemic Control as Primary Prevention for Diabetic Kidney DiseaseMacIsaac RJ, Jerums G, Ekinci EI — March 2018
  111. 137JournalOne size does not fit all glycemic targets for type 2 diabetesPozzilli P, Strollo R, Bonora E — March 2014
  112. 138Type 1 diabetes in adults: diagnosis and managementNational Institute for Health and Care Excellence — 26 August 2015
  113. 139Type 2 diabetes in adults: managementNational Institute for Health and Care Excellence — 2 December 2015
  114. 140JournalManagement of blood glucose in type 2 diabetes mellitusRipsin CM, Kang H, Urban RJ — January 2009
  115. 141JournalOral antidiabetic agents: current role in type 2 diabetes mellitusKrentz AJ, Bailey CJ — 2005
  116. 142Choosing a type 2 diabetes drug – Why the best first choice is often the oldest drugConsumer Reports et al. — Consumer Reports — April 2012
  117. 143JournalA Roadmap on the Prevention of Cardiovascular Disease Among People Living With DiabetesMitchell S, Malanda B, Damasceno A, Eckel RH, Gaita D, Kotseva K, Januzzi JL, Mensah G, Plutzky J, Prystupiuk M, Ryden L, Thierer J, Virani SS, Sperling L — September 2019
  118. 144JournalEffect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analysesBrunström M, Carlberg B — February 2016
  119. 145JournalBenefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trialsBrunström M, Carlberg B — September 2019
  120. 146JournalUpdate on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes AssociationFox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, Inzucchi SE, Kosiborod M, Nelson RG, Patel MJ, Pignone M, Quinn L, Schauer PR, Selvin E, Vafiadis DK — September 2015
  121. 147JournalEffect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysisCheng J, Zhang W, Zhang X, Han F, Li X, He X, Li Q, Chen J — May 2014
  122. 148JournalEffects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patientsZheng SL, Roddick AJ, Ayis S — September 2017
  123. 149JournalCardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-AnalysesCatalá-López F, Macías Saint-Gerons D, González-Bermejo D, Rosano GM, Davis BR, Ridao M, Zaragoza A, Montero-Corominas D, Tobías A, de la Fuente-Honrubia C, Tabarés-Seisdedos R, Hutton B — March 2016
  124. 150JournalAspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology FoundationPignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS — June 2010
  125. 151JournalThe clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluationPicot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ — September 2009
  126. 152JournalBariatric surgery for diabetes managementFrachetti KJ, Goldfine AB — April 2009
  127. 153JournalBariatric surgery in patients with type 2 diabetes: a viable optionColucci RA — January 2011
  128. 154Journal"Metabolic" surgery for treatment of type 2 diabetes mellitusSchulman AP, del Genio F, Sinha N, Rubino F — September–October 2009
  129. 155JournalBariatric surgery for type 2 diabetesDixon JB, le Roux CW, Rubino F, Zimmet P — June 2012
  130. 156Pancreas TransplantationAmerican Diabetes Association
  131. 157JournalPrevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysisSun J, Wang Y, Zhang X, Zhu S, He H — October 2020
  132. 158JournalAdvances in Interventional Therapies for Painful Diabetic Neuropathy: A Systematic ReviewXu L, Sun Z, Casserly E, Nasr C, Cheng J, Xu J — June 2022
  133. 159JournalSurgical Decompression in the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Meta-analysisTu Y, Lineaweaver WC, Chen Z, Hu J, Mullins F, Zhang F — March 2017
  134. 160JournalA cause for optimism in diabetic neuropathyDellon AL — February 1988
  135. 161JournalBiologic Basis of Nerve Decompression Surgery for Focal Entrapments in Diabetic Peripheral NeuropathySessions J, Nickerson DS — March 2014
  136. 162JournalLower Extremity Nerve Decompression for Diabetic Peripheral Neuropathy: A Systematic Review and Meta-analysisFadel ZT, Imran WM, Azhar T — August 2022
  137. 164JournalHome telehealth for diabetes management: a systematic review and meta-analysisPolisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K — October 2009
  138. 165JournalComputer-based diabetes self-management interventions for adults with type 2 diabetes mellitusPal K, Eastwood SV, Michie S, Farmer AJ, Barnard ML, Peacock R, Wood B, Inniss JD, Murray E — March 2013
  139. 166JournalComputer-assisted versus oral-and-written dietary history taking for diabetes mellitusWei I, Pappas Y, Car J, Sheikh A, Majeed A — December 2011
  140. 167JournalThe global implications of diabetes and cancerShi Y, Hu FB — June 2014
  141. 168Global Report on DiabetesWorld Health Organization — 2016
  142. 169BookEstimated number diabetics worldwideElflein J — 10 December 2019
  143. 170JournalYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010T. Vos et al. — December 2012
  144. 171JournalDiabetes and genderGale EA, Gillespie KM — January 2001
  145. 172JournalSex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort studyMeisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H — January 2002
  146. 173The top 10 causes of death Fact sheet N°310World Health Organization — October 2013
  147. 174JournalProjections of global mortality and burden of disease from 2002 to 2030Mathers CD, Loncar D — November 2006
  148. 175JournalGlobal prevalence of diabetes: estimates for the year 2000 and projections for 2030Wild S, Roglic G, Green A, Sicree R, King H — May 2004
  149. 177BookExercise and disease managementRipoll BC, Leutholtz I — CRC Press — 2011-04-25
  150. 178MagazineSickening sweetRoberts J — 2015
  151. 179BookPrinciples of diabetes mellitusSpringer — 2009
  152. 180BookThe History of Diabetes MellitusN.S Papaspyros — Thieme — 1964
  153. 181JournalAretaeus of Cappadocia and the first description of diabetesLaios K, Karamanou M, Saridaki Z, Androutsos G — 2012
  154. 182Online Etymology Dictionary. diabetes.Harper D — 2001–2010
  155. 185JournalDiabetes urine testing: an historical perspectiveGuthrie DW, Humphreys SS — 1988
  156. 186BookThe New Public Health, Second EditionTulchinsky TH, Varavikova EA — Academic Press — 2008
  157. 187JournalMonitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering CommitteePiwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M — May 1993
  158. 188JournalType 2 diabetes programmes in EuropeDubois H, Bankauskaite V — 2005
  159. 190JournalSocial stigma in diabetes: a framework to understand a growing problem for an increasing epidemicSchabert J, Browne JL, Mosely K, Speight J — 2013-03-01
  160. 191JournalWeight stigma and diabetes stigma in U.S. adults with type 2 diabetes: Associations with diabetes self-care behaviors and perceptions of health carePuhl RM, Himmelstein MS, Hateley-Browne JL, Speight J — October 2020
  161. 192JournalRace/ethnic difference in diabetes and diabetic complicationsSpanakis EK, Golden SH — December 2013
  162. 195JournalLost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforceStewart WF, Ricci JA, Chee E, Hirsch AG, Brandenburg NA — June 2007
  163. 196JournalEmergency Department Visits for Adults with Diabetes, 2010Washington RE, Andrews RM, Mutter R — Agency for Healthcare Research and Quality — November 2013
  164. 197JournalSex inequalities in access to care for patients with diabetes in primary care: questionnaire survey.J Hippisley-Cox et al. — May 2006
  165. 199JournalGender differences in diabetes self-care in adults with type 1 diabetes: Findings from the T1D Exchange clinic registry.VN Shah et al. — October 2018
  166. 201BookLiving with diabetesParker K — Facts On File — 2008
  167. 203JournalComparative occurrence of diabetes in canine, feline, and few wild animals and their association with pancreatic diseases and ketoacidosis with therapeutic approachNiaz K, Maqbool F, Khan F, Hassan FI, Momtaz S, Abdollahi M — April 2018
  168. 204BookReptile Medicine and SurgeryStahl SJ — W.B. Saunders — 2006-01-01
  169. 205JournalRevisiting glucose regulation in birds - A negative model of diabetes complicationsSweazea KL — 8 July 2022
  170. 208BookFeline diabetes mellitus Aspects on epidemiology and pathogenesisÖhlund M — Acta Universitatis agriculturae Sueciae